Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA.
暂无分享,去创建一个
W. Gerald | J. Satagopan | Longgui Wang | Zhengxin Wang | I. Osman | Yirong Li | Peng Lee | Yirong Li | Iman Osman | Longgui Wang | Xuanyi Zou | Aaron D Berger | Christian Twiss | Yi Peng | Jason Chiu | Hongfeng Guo | Jaya Satagopan | Andrew Wilton | William Gerald | Ross Basch | Zhengxin Wang | Peng Lee | R. Basch | Xuanyi Zou | J. Chiu | A. Wilton | A. Berger | C. Twiss | Yi Peng | Hong Guo
[1] Ping Zhu,et al. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. , 2004, Cancer cell.
[2] E. Latulippe,et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. , 2002, Cancer research.
[3] R. Kingston,et al. Cooperation between Complexes that Regulate Chromatin Structure and Transcription , 2002, Cell.
[4] J. Winnie,et al. Invasion of v-FosFBR-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes , 2004, Oncogene.
[5] Rakesh Kumar,et al. Emerging roles of MTA family members in human cancers. , 2003, Seminars in oncology.
[6] V. Reinke,et al. Regulation of tissue-specific and extracellular matrix-related genes by a class I histone deacetylase. , 2005, Molecular cell.
[7] Rudolf Fahlbusch,et al. Suberoylanilide hydroxamic acid (SAHA) has potent anti‐glioma properties in vitro, ex vivo and in vivo , 2005, Journal of neurochemistry.
[8] N. Bertos,et al. Class II histone deacetylases: structure, function, and regulation. , 2001, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[9] E. Gelmann,et al. Molecular biology of the androgen receptor. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Yin-Won Lee,et al. Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials. , 2004, Biochemical and biophysical research communications.
[11] L. Ossowski,et al. Activation of Rb and decline in androgen receptor protein precede retinoic acid–induced apoptosis in androgen‐dependent LNCaP cells and their androgen‐independent derivative , 1999, Journal of cellular physiology.
[12] Y. Mitani,et al. Histone Acetylation and Gastrointestinal Carcinogenesis , 2003, Annals of the New York Academy of Sciences.
[13] Zhengxin Wang,et al. Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer , 2008, Proceedings of the National Academy of Sciences.
[14] D. Neal,et al. Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate. , 2004, European urology.
[15] Tao Liu,et al. Histone deacetylase inhibitors: multifunctional anticancer agents. , 2006, Cancer treatment reviews.
[16] J. Qin,et al. Both corepressor proteins SMRT and N‐CoR exist in large protein complexes containing HDAC3 , 2000, The EMBO journal.
[17] D. Coradini,et al. Inhibition of Hepatocellular Carcinomas in vitro and Hepatic Metastases in vivo in Mice by the Histone Deacetylase Inhibitor HA-But , 2004, Clinical Cancer Research.
[18] Z. Culig. Role of the androgen receptor axis in prostate cancer. , 2003, Urology.
[19] F. Dequiedt,et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. , 2002, Molecular cell.
[20] J. Chiao,et al. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate. , 2006, Carcinogenesis.
[21] R. Dahiya,et al. Histone deacetylase and DNA methyltransferase in human prostate cancer. , 2001, Biochemical and biophysical research communications.
[22] W. Gerald,et al. Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70. , 2008, The American journal of pathology.
[23] R. Lanz,et al. Nuclear receptor coregulators: cellular and molecular biology. , 1999, Endocrine reviews.
[24] M. Pincus,et al. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations , 2008, Oncogene.
[25] Hee June Choi,et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes , 2005, Nature.
[26] Hing Y Leung,et al. Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer , 2004, The Prostate.
[27] W. Isaacs,et al. Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines. , 2006, Experimental cell research.
[28] Michael L. Blackburn,et al. An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B. , 2003, The Biochemical journal.
[29] B. Aggarwal,et al. Suberoylanilide Hydroxamic Acid Potentiates Apoptosis, Inhibits Invasion, and Abolishes Osteoclastogenesis by Suppressing Nuclear Factor-κB Activation* , 2006, Journal of Biological Chemistry.
[30] Chawnshang Chang,et al. Androgen receptor corepressors: An overview , 2005, The Prostate.
[31] L. Ossowski,et al. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line. , 2001, Cancer research.
[32] W. Gerald,et al. The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells. , 2005, Molecular endocrinology.
[33] W. D. Cress,et al. Histone deacetylases, transcriptional control, and cancer , 2000, Journal of cellular physiology.
[34] D. Budman,et al. Unique induction of p21WAF1/CIP1expression by vinorelbine in androgen-independent prostate cancer cells , 2003, British Journal of Cancer.